A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome

Yuri Ann Saito Loftus, G. R. Locke, J. M. Zimmerman, G. Holtmann, J. P. Slusser, Mariza De Andrade, Gloria M Petersen, N. J. Talley

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

A pharmacogenetic study suggests the 5-HTT LPR polymorphism predicts response to alosetron, and another study describes a possible association of the GNβ3 C825T polymorphism with IBS in patients with dyspepsia. We performed a case-control association study to determine whether these polymorphisms are associated with irritable bowel syndrome (IBS). The study aim was to compare allele and genotype frequencies between cases and controls for the 5-HTT LPR and the GNβ3 C825T polymorphism. Cases were 50 GI outpatients; controls were 53 General Medicine outpatients matched to cases for age, gender and race at a major medical centre. Participants completed a questionnaire and donated blood. DNA was genotyped using polymerase chain reaction based assays. Eighty-two per cent of cases met Rome II criteria for IBS: 12% constipation-, 46% diarrhoea-, and 42% mixed-IBS. Genotype and allele frequencies for both polymorphisms did not differ between cases and controls. However, the allele frequency of the short (S) allele of the 5-HTT LPR polymorphism was greater in those with mixed-IBS compared with controls (68%vs 45%, P < 0.05). This study suggests that the 5-HTT LPR polymorphism may be associated with mixed-IBS, but not IBS overall. No association was observed for the GNβ3 C825T polymorphism with IBS overall or subtypes.

Original languageEnglish (US)
Pages (from-to)465-470
Number of pages6
JournalNeurogastroenterology and Motility
Volume19
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Irritable Bowel Syndrome
Genetic Association Studies
Gene Frequency
Outpatients
Genotype
Dyspepsia
Constipation
Case-Control Studies
Diarrhea
Alleles
Medicine
Polymerase Chain Reaction
DNA

Keywords

  • G-protein
  • Genetic polymorphisms
  • Irritable bowel syndrome
  • Serotonin transporter

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology
  • Neuroscience(all)

Cite this

A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome. / Saito Loftus, Yuri Ann; Locke, G. R.; Zimmerman, J. M.; Holtmann, G.; Slusser, J. P.; De Andrade, Mariza; Petersen, Gloria M; Talley, N. J.

In: Neurogastroenterology and Motility, Vol. 19, No. 6, 06.2007, p. 465-470.

Research output: Contribution to journalArticle

@article{2e5b41ac641041109c3c306a2514d0f2,
title = "A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome",
abstract = "A pharmacogenetic study suggests the 5-HTT LPR polymorphism predicts response to alosetron, and another study describes a possible association of the GNβ3 C825T polymorphism with IBS in patients with dyspepsia. We performed a case-control association study to determine whether these polymorphisms are associated with irritable bowel syndrome (IBS). The study aim was to compare allele and genotype frequencies between cases and controls for the 5-HTT LPR and the GNβ3 C825T polymorphism. Cases were 50 GI outpatients; controls were 53 General Medicine outpatients matched to cases for age, gender and race at a major medical centre. Participants completed a questionnaire and donated blood. DNA was genotyped using polymerase chain reaction based assays. Eighty-two per cent of cases met Rome II criteria for IBS: 12{\%} constipation-, 46{\%} diarrhoea-, and 42{\%} mixed-IBS. Genotype and allele frequencies for both polymorphisms did not differ between cases and controls. However, the allele frequency of the short (S) allele of the 5-HTT LPR polymorphism was greater in those with mixed-IBS compared with controls (68{\%}vs 45{\%}, P < 0.05). This study suggests that the 5-HTT LPR polymorphism may be associated with mixed-IBS, but not IBS overall. No association was observed for the GNβ3 C825T polymorphism with IBS overall or subtypes.",
keywords = "G-protein, Genetic polymorphisms, Irritable bowel syndrome, Serotonin transporter",
author = "{Saito Loftus}, {Yuri Ann} and Locke, {G. R.} and Zimmerman, {J. M.} and G. Holtmann and Slusser, {J. P.} and {De Andrade}, Mariza and Petersen, {Gloria M} and Talley, {N. J.}",
year = "2007",
month = "6",
doi = "10.1111/j.1365-2982.2007.00905.x",
language = "English (US)",
volume = "19",
pages = "465--470",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome

AU - Saito Loftus, Yuri Ann

AU - Locke, G. R.

AU - Zimmerman, J. M.

AU - Holtmann, G.

AU - Slusser, J. P.

AU - De Andrade, Mariza

AU - Petersen, Gloria M

AU - Talley, N. J.

PY - 2007/6

Y1 - 2007/6

N2 - A pharmacogenetic study suggests the 5-HTT LPR polymorphism predicts response to alosetron, and another study describes a possible association of the GNβ3 C825T polymorphism with IBS in patients with dyspepsia. We performed a case-control association study to determine whether these polymorphisms are associated with irritable bowel syndrome (IBS). The study aim was to compare allele and genotype frequencies between cases and controls for the 5-HTT LPR and the GNβ3 C825T polymorphism. Cases were 50 GI outpatients; controls were 53 General Medicine outpatients matched to cases for age, gender and race at a major medical centre. Participants completed a questionnaire and donated blood. DNA was genotyped using polymerase chain reaction based assays. Eighty-two per cent of cases met Rome II criteria for IBS: 12% constipation-, 46% diarrhoea-, and 42% mixed-IBS. Genotype and allele frequencies for both polymorphisms did not differ between cases and controls. However, the allele frequency of the short (S) allele of the 5-HTT LPR polymorphism was greater in those with mixed-IBS compared with controls (68%vs 45%, P < 0.05). This study suggests that the 5-HTT LPR polymorphism may be associated with mixed-IBS, but not IBS overall. No association was observed for the GNβ3 C825T polymorphism with IBS overall or subtypes.

AB - A pharmacogenetic study suggests the 5-HTT LPR polymorphism predicts response to alosetron, and another study describes a possible association of the GNβ3 C825T polymorphism with IBS in patients with dyspepsia. We performed a case-control association study to determine whether these polymorphisms are associated with irritable bowel syndrome (IBS). The study aim was to compare allele and genotype frequencies between cases and controls for the 5-HTT LPR and the GNβ3 C825T polymorphism. Cases were 50 GI outpatients; controls were 53 General Medicine outpatients matched to cases for age, gender and race at a major medical centre. Participants completed a questionnaire and donated blood. DNA was genotyped using polymerase chain reaction based assays. Eighty-two per cent of cases met Rome II criteria for IBS: 12% constipation-, 46% diarrhoea-, and 42% mixed-IBS. Genotype and allele frequencies for both polymorphisms did not differ between cases and controls. However, the allele frequency of the short (S) allele of the 5-HTT LPR polymorphism was greater in those with mixed-IBS compared with controls (68%vs 45%, P < 0.05). This study suggests that the 5-HTT LPR polymorphism may be associated with mixed-IBS, but not IBS overall. No association was observed for the GNβ3 C825T polymorphism with IBS overall or subtypes.

KW - G-protein

KW - Genetic polymorphisms

KW - Irritable bowel syndrome

KW - Serotonin transporter

UR - http://www.scopus.com/inward/record.url?scp=34250172717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250172717&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2982.2007.00905.x

DO - 10.1111/j.1365-2982.2007.00905.x

M3 - Article

C2 - 17564628

AN - SCOPUS:34250172717

VL - 19

SP - 465

EP - 470

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 6

ER -